Adam Cook, Age 42Westminster, CO

Adam Cook Phones & Addresses

Thornton, CO

Aurora, CO

Work

Company: Red robin gourmet burgers Oct 2007 Position: Certified in all front of house positions

Education

School / High School: THORNTON HIGH SCHOOL- Thornton, CO May 2005 Specialities: General Studies

Mentions for Adam Cook

Career records & work history

License Records

Adam Gregory Cook

Licenses:
License #: 72401 - Expired
Category: Nursing Support
Issued Date: Jun 11, 2012
Effective Date: Jun 23, 2014
Expiration Date: Jun 11, 2014
Type: Medication Aide

Adam Cook resumes & CV records

Resumes

Adam Cook Photo 47

Adam Cook - Lochbuie, CO

Work:
Red Robin Gourmet Burgers Oct 2007 to 2000
Certified In all Front of House Positions
Boondocks Fun Center - Northglenn, CO May 2005 to Sep 2007
Team Leader of the Go-Karts
Education:
THORNTON HIGH SCHOOL - Thornton, CO May 2005
General Studies
METROPOLITAN STATE COLLEGE OF DENVER - Denver, CO
Business Management

Publications & IP owners

Us Patents

Reactor Plate Washing Station

US Patent:
6403379, Jun 11, 2002
Filed:
Sep 3, 1999
Appl. No.:
09/390251
Inventors:
Mark Munson - Louisville CO
Adam Cook - Longmont CO
Philip Loudin - Boulder CO
Assignee:
Array BioPharma - Boulder CO
International Classification:
G01N 3510
US Classification:
436 43, 422101, 422102, 422 99, 422 65, 436 49
Abstract:
Provided is a manually operated wash station that can simultaneously apply a wash process to multiple cells of a multi-well synthesis reactor plate. Further provided is a manually operated wash station that can be adapted to automatic computer control. A method for simultaneously washing a plurality of wells in a multi-well container is provided. Additionally, a method for purifying a plurality of chemical products simultaneously in a multi-well reactor plate.

Compounds Useful For Inhibiting Chk1

US Patent:
7560462, Jul 14, 2009
Filed:
Jul 1, 2005
Appl. No.:
11/630626
Inventors:
John Joseph Gaudino - Longmont CO, US
Adam Wade Cook - Broomfield CO, US
Assignee:
ICOS Corporation - Bothell WA
International Classification:
A61K 31/497
C07D 401/10
C07D 403/10
C07D 405/10
C07D 409/10
C07D 411/10
C07D 413/10
C07D 417/10
C07D 419/10
A61P 35/00
C07D 241/14
C07D 241/16
C07D 241/20
C07D 211/70
C07D 211/84
C07D 213/89
US Classification:
51425505, 544405, 544406, 544407, 544408, 544336, 546329, 548235, 548202, 548201, 548205, 548200, 564 74, 568940, 556422
Abstract:
Substituted urea compounds useful in the treatment of diseases and CalkyleneORconditions related to DNA damage or lesions in DNA replication are disclosed formula (I), wherein Xis null, —O—, —S—, —CH—, or —N(R)—; Xis —O—,. ->. -, or —N(R)—,—. . Y xs 0 or S; or =y represents two hydrogen atoms attached to a common carbon atom, —W is selected from the group consisting of heteroaryl, aryl, heterocycloalkyl, cycloalkyl, and alkyl substituted with a heteroaryl. or aryl group; Ris —C≡C—Ror heteroaryl; R, R, and R, independently, are selected from the group consisting of halo, optionally substituted Calkyl, Calkenyl, Calkynyl, OCP, CF, NO, CN, NC, N(R), OR, COR, C(O)N (R), C(O)R, N(R)COR, N(R)C(O)OR, N(R)C(O)OR, N(R)C(O)CalkyleneC(O)R, N(R)C(O)CalkyleneC(O)OR, N(R)C(O)CalkyleneOR, N(R)C(O)CalkyleneNHC(O)OR, N(R)C(O)CalkyleneSO. NR, CalkyleneOR, and SR; Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division also are disclosed.

Heteroaryl Urea Derivatives Useful For Inhibiting Chk1

US Patent:
8093244, Jan 10, 2012
Filed:
Mar 29, 2006
Appl. No.:
11/908416
Inventors:
Frank Diaz - Florence AL, US
Francine S. Farouz - San Diego CA, US
Ryan Coatsworth Holcomb - Salt Lake City UT, US
Edward A. Kesicki - Bothell WA, US
Kimba Lee Fischer - Longmont CO, US
Adam Wade Cook - Broomfield CO, US
Assignee:
ICOS Corporation - Indianapolis IN
International Classification:
A61P 35/00
A61K 31/497
A61K 31/5355
A61K 31/541
C07D 403/12
C07D 413/12
C07D 417/12
US Classification:
5142358, 544120
Abstract:
Substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division, also are disclosed.

4-Substituted Phenoxyphenylacetic Acid Derivatives

US Patent:
8183289, May 22, 2012
Filed:
Aug 21, 2007
Appl. No.:
12/438112
Inventors:
George Doherty - Libertyville IL, US
Adam Cook - Broomfield CO, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
C07D 211/22
C07D 211/84
C07D 333/22
C07D 233/00
C07C 229/00
A01N 37/12
A01N 37/44
US Classification:
514563, 546316, 5483235, 549 77, 562455
Abstract:
Compounds of Formula (I): in which R, R, R, R, R, Rand A have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

4-Substituted Phenoxyphenylacetic Acid Derivatives

US Patent:
8492437, Jul 23, 2013
Filed:
Apr 17, 2012
Appl. No.:
13/448689
Inventors:
George A. Doherty - Libertyville IL, US
Adam Cook - Broomfield CO, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
C07D 211/22
C07D 211/84
C07D 333/22
C07D 233/00
C07C 229/00
A01N 37/12
A01N 37/44
US Classification:
514563, 546316, 5483235, 549 77, 562455
Abstract:
Compounds of formula (I):.

6-Substituted Phenoxychroman Carboxylic Acid Derivatives

US Patent:
8569522, Oct 29, 2013
Filed:
Jun 24, 2009
Appl. No.:
13/001201
Inventors:
Laurence E. Burgess - Boulder CO, US
Christopher T. Clark - Denver CO, US
Adam Cook - Boulder CO, US
Christopher P. Corrette - Boulder CO, US
Robert Kirk DeLisle - Longmont CO, US
George A. Doherty - Libertyville IL, US
Kevin W. Hunt - Boulder CO, US
Todd T. Romoff - Bradenton FL, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
C07D 311/58
A61K 31/353
US Classification:
549405, 514456
Abstract:
Compounds of Formula (I): in which A, A, W, L, G, R, R, R, Rand Rhave the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

Compounds For Treating Neurodegenerative Diseases

US Patent:
2012006, Mar 15, 2012
Filed:
Mar 31, 2011
Appl. No.:
13/077477
Inventors:
Christopher T. Clark - Boulder CO, US
Adam Cook - Boulder CO, US
Indrani W. Gunawardana - Boulder CO, US
Kevin W. Hunt - Boulder CO, US
Nicholas C. Kallan - Boulder CO, US
Michael Siu - South San Francisco CA, US
Allen A. Thomas - Boulder CO, US
Matthew Volgraf - South San Francisco CA, US
International Classification:
A61K 31/547
A61K 31/527
A61K 31/4439
A61K 31/423
A61K 31/4184
C07D 279/08
C07D 413/10
C07D 401/14
C07D 263/52
C07D 235/02
C07D 417/10
A61P 25/28
C07D 403/10
C07D 401/10
C07D 491/107
A61K 31/506
US Classification:
5142272, 514256, 514272, 514278, 514377, 514389, 544 6, 544230, 544231, 546 15, 548216, 5483011
Abstract:
The invention provides novel spirotetrahydronaphthalene compounds of Formula α that inhibit β-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.

7-Phenoxychroman Carboxylic Acid Derivatives

US Patent:
2012010, Apr 26, 2012
Filed:
Dec 18, 2009
Appl. No.:
13/141675
Inventors:
Adam Cook - Boulder CO, US
Kevin W. Hunt - Boulder CO, US
Robert Kirk Delisle - Boulder CO, US
Todd Romoff - Bradenton FL, US
Christopher T. Clark - Boulder CO, US
Ganghyeok Kim - Boulder CO, US
Christopher P. Corrette - Boulder CO, US
George A. Doherty - Boulder CO, US
Laurence E. Burgess - Boulder CO, US
Assignee:
ARRAY BIOPHARMA INC. - Boulder CO
International Classification:
A61K 31/498
A61K 31/497
A61K 31/506
A61K 31/4709
A61K 31/453
A61K 31/444
A61K 31/4433
A61K 31/433
A61K 31/427
A61K 31/428
A61K 31/423
A61K 31/4155
A61K 31/4025
C07D 405/14
C07D 405/12
C07D 417/12
A61K 31/501
US Classification:
514249, 51425201, 51425505, 514274, 514313, 514318, 514333, 514337, 514363, 514365, 514367, 514375, 514406, 514422, 544238, 544311, 544356, 544405, 546159, 546194, 546256, 5462827, 548139, 548159, 548204, 548222, 5483644, 548525
Abstract:
Compounds of Formula I: (I) in which A, A, R, R, R, Rand Rhave the meanings given in the specification, are DP2 receptor inhibitors useful in the treatment of useful in the treatment and prevention of immunologic diseases, allergic diseases such as asthma, allergic rhinitis and atopic dermatitis, and other inflammatory diseases mediated by prostaglandin D(PGD). The compounds of Formula I may also be useful in treating diseases or medical conditions involving the Th2 T cell via production of IL-4, IL-5 and/or IL-13.

Isbn (Books And Publications)

Mobile Suit Gundam: Federation Vs. Zeon Official Strategy Guide

Author:
Adam Cook
ISBN #:
0744002036

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.